Roche Holding Ltd
Stock
Stock
ISIN: CH1499059983
Ticker: ROP
CH1499059983
ROP
Price
Price
CHART BY
Historical dividends and forecast
Roche Holding Ltd has so far distributed $12.43 in 2026. The next dividend will be paid on 16.03.2027
$4.926
CHART BY
Frequently asked questions
What is Roche Holding Ltd's market capitalization?
The market capitalization of Roche Holding Ltd is CHF 253.01B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Roche Holding Ltd's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Roche Holding Ltd is 19.65. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Roche Holding Ltd?
Roche Holding Ltd's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $16.18. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Roche Holding Ltd's stock?
Currently, 25 analysts cover Roche Holding Ltd's stock, with a consensus target price of CHF 358.70. Analyst ratings provide insights into the stock's expected performance.
What is Roche Holding Ltd's revenue over the trailing twelve months?
Over the trailing twelve months, Roche Holding Ltd reported a revenue of CHF 61.52B.
What is the EBITDA for Roche Holding Ltd?
Roche Holding Ltd's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is CHF 22.36B. EBITDA measures the company's overall financial performance.
What is the free cash flow of Roche Holding Ltd?
Roche Holding Ltd has a free cash flow of CHF 14.08B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Roche Holding Ltd have, and what sector and industry does it belong to?
Roche Holding Ltd employs approximately 112,774 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
Financials
- Market Cap
- CHF 253.01B
- EPS (TTM)
- $16.18
- P/E ratio (TTM)
- 19.65
- Revenue (TTM)
- CHF 61.52B
- EBITDA (TTM)
- CHF 22.36B
- Free Cashflow (TTM)
- CHF 14.08B
Pricing
- 52W span
- $271.12$484.43
Analyst Ratings
The price target is CHF 358.70 and the stock is covered by 25 analysts.
Buy
13
Hold
9
Sell
3
Information
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
- Employees
- 112,774
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- CH1499059983
- Primary Ticker
- ROP
Fundamentals & EOD data from FactSet